Effect of ArginMax on sexual functioning and quality of life among female cancer survivors: results of the WFU CCOP Research Base Protocol 97106.

ABSTRACT:

Background

Problems with sexual functioning are common following therapy for breast and gynecologic cancers, although there are few effective treatments.

Objective

To assess the impact of ArginMax, a nutritional supplement comprised of extracts of L-arginine, ginseng, gingko, and damiana, as well as multivitamins and minerals, on sexual functioning and quality of life in female cancer survivors.

Methods

This was a 12-week, randomized, placebo-controlled trial of eligible patients who were 6 months or more from active treatment and reporting problems with sexual interest, satisfaction, and functioning after therapy. The participants took 3 capsules of Arginmax or placebo twice daily. Outcome measures were the Female Sexual Function Inventory (FSFI) and the Functional A

SUBMITTER: Greven KM 

PROVIDER: S-EPMC4544777 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature